Back
About
Mangoceuticals, Inc. offers a telemedicine service specializing in the treatment of erectile dysfunction. Mangoceuticals' target market covers about one-third of the male population.
Through the recently launched web service MangoRX, patients can contact medical specialists, receive referrals for tests, prescriptions for medications, and immediately order the required drugs.
To date, Mangoceuticals has obtained a license for an online pharmacy and is preparing to commercially launch its own drug called Mango ED. It includes components already approved by the U.S. Food and Drug Administration (FDA). Therefore, Mangoceuticals plans to sell the drug in individual doses not as a medication, but under a simpler regulatory scheme that pertains to dietary supplements and cosmetics. This approach reduces costs, but competitors can use the recipe.
Mangoceuticals plans to use the funds from the IPO to finance the marketing of the Mango ED drug and launch sales in the next quarter, following the IPO.
_______________________________
Number of employees: 2-10
______________________________
Headquarters location: Dallas, Texas, USA.
Calls within Tajikistan are free
Investments
Information
The information provided is for informational purposes only and should not be considered as an offer to buy or sell foreign currency, securities and/or other financial instruments. The information presented on this website is not an individual investment recommendation. Financial instruments or transactions mentioned in this section may not be suitable for you, may not correspond to your investment profile, financial situation, investment experience, knowledge, investment objectives, attitude to risk and profitability.
LLC "Exchange Broker" does not guarantee and does not promise future profitability of investments, does not guarantee the reliability of possible investments and the stability of possible income. Investment results in the past do not guarantee income in the future.
LLC "Exchange Broker" is not responsible for possible investor losses in the event of transactions and investments in financial instruments, and also does not guarantee the return, effectiveness and profitability of investments.
LLC "Exchange Broker" hereby informs that it operates in the securities market in accordance with the following professional participant licenses issued by the Ministry of Finance of the Republic of Tajikistan: depository activity No.010/25 dated 25.06.2025; brokerage activity No.007/25 dated 25.06.2025; dealer activity No.008/25 dated 25.06.2025 and securities management activity No.009/25 dated 25.06.2025, and also informs about the risk of a conflict of interest, including as a result of combining various types of professional activity in the securities market.